Rafa Laboratories Ltd. (TLV:RAFA)
1,469.00
-4.00 (-0.27%)
At close: Aug 13, 2026
Rafa Laboratories Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| 459.86 | 418.44 | 420.08 | 355.2 | |
Revenue Growth | - | -0.39% | 18.27% | - |
Cost of Revenue | 237.04 | 220.33 | 218.88 | 196.91 |
Gross Profit | 222.82 | 198.11 | 201.2 | 158.29 |
Selling, General & Admin | 83.61 | 81.7 | 82.07 | 76.62 |
Research & Development | 3.77 | 4.08 | 4.49 | 2.68 |
Other Operating Expenses | 0.66 | 0.66 | 0.62 | 0.69 |
Operating Expenses | 88.04 | 86.44 | 87.19 | 79.98 |
Operating Income | 134.77 | 111.67 | 114.01 | 78.31 |
Interest Expense | -1.15 | -0.91 | -1.22 | -1.31 |
Interest & Investment Income | 1.38 | 0.62 | 0.23 | 0.13 |
Earnings From Equity Investments | 0.58 | 0.01 | -1.19 | -2.11 |
Currency Exchange Gain (Loss) | -2.1 | -2.1 | -1.61 | 0.32 |
Other Non Operating Income (Expenses) | 0.32 | 0.32 | 0.24 | - |
EBT Excluding Unusual Items | 133.79 | 109.61 | 110.47 | 75.35 |
Gain (Loss) on Sale of Investments | 1.2 | 1.2 | -0.24 | 0.38 |
Pretax Income | 135 | 110.81 | 110.23 | 75.73 |
Income Tax Expense | 11.83 | 10.47 | 10.8 | 9.51 |
Net Income | 123.16 | 100.34 | 99.43 | 66.22 |
Net Income to Common | 123.16 | 100.34 | 99.43 | 66.22 |
Net Income Growth | - | 0.91% | 50.16% | - |
Shares Outstanding (Basic) | 2,855 | 2,867 | 2,924 | 2,879 |
Shares Outstanding (Diluted) | 2,855 | 2,951 | 2,924 | 3,010 |
Shares Change | - | 0.91% | -2.84% | - |
EPS (Basic) | 0.04 | 0.04 | 0.03 | 0.02 |
EPS (Diluted) | 0.04 | 0.03 | 0.03 | 0.02 |
EPS Growth | - | 0% | 54.55% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 111.38 | 95.15 | 135.71 | 33.16 |
Free Cash Flow Per Share | 0.04 | 0.03 | 0.05 | 0.01 |
Gross Margin | 48.45% | 47.34% | 47.89% | 44.56% |
Operating Margin | 29.31% | 26.69% | 27.14% | 22.05% |
Profit Margin | 26.78% | 23.98% | 23.67% | 18.64% |
Free Cash Flow Margin | 24.22% | 22.74% | 32.30% | 9.34% |
EBITDA | 144.19 | 120.85 | 122.59 | 90.14 |
EBITDA Margin | 31.36% | 28.88% | 29.18% | 25.38% |
D&A For EBITDA | 9.42 | 9.19 | 8.57 | 11.83 |
EBIT | 134.77 | 111.67 | 114.01 | 78.31 |
EBIT Margin | 29.31% | 26.69% | 27.14% | 22.05% |
Effective Tax Rate | 8.77% | 9.45% | 9.80% | 12.56% |
Advertising Expenses | - | 14.31 | 15.77 | 13.82 |